Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PureTech Health (PRTC) Cash & Current Investments (2019 - 2025)

PureTech Health (PRTC) has disclosed Cash & Current Investments for 7 consecutive years, with $252.5 million as the latest value for Q4 2025.

  • For Q4 2025, Cash & Current Investments fell 10.04% year-over-year to $252.5 million; the TTM value through Dec 2025 reached $252.5 million, down 10.04%, while the annual FY2025 figure was $252.5 million, 10.04% down from the prior year.
  • Cash & Current Investments hit $252.5 million in Q4 2025 for PureTech Health, down from $280.6 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $465.7 million in Q4 2021 and bottomed at $191.1 million in Q4 2023.
  • Average Cash & Current Investments over 5 years is $308.0 million, with a median of $280.6 million recorded in 2024.
  • Year-over-year, Cash & Current Investments crashed 45.42% in 2023 and then surged 46.87% in 2024.
  • PureTech Health's Cash & Current Investments stood at $465.7 million in 2021, then fell by 24.83% to $350.1 million in 2022, then plummeted by 45.42% to $191.1 million in 2023, then soared by 46.87% to $280.6 million in 2024, then fell by 10.04% to $252.5 million in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $252.5 million, $280.6 million, and $191.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.